Educational Intervention in Patients With Migraine
Launched by BASQUE HEALTH SERVICE · Dec 21, 2017
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study was to assess the effectiveness of a group educational intervention about concepts of pain neuroscience, in the management of migraine, compared to routine medical interventions, in primary care health centres of Alava.
After recruitment, patients were interviewed by the research team members in charge of the assessments. In these interviews, data were collected on the following: demographic characteristics, beliefs regarding migraine, coping strategies for migraine attacks, the MIDAS questionnaire (16), medication taken, work leave, emergency department attendances a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Belong to one of these health centres of primary care: San Martín, Sansomendi, Lakuarriaga, Gazalbide and Zabalgana,
- • Diagnosed with migraine (ICD-9-CM Diagnosis Code 346) who had at least one migraine attack every month despite treatment.
- Exclusion Criteria:
- • We excluded patients with mental illness, cognitive impairment or language deficits that might hinder completion of follow-up and patients that would not be able to attend to all the sessions of the intervention or had received training as part of the previous pilot study.
About Basque Health Service
The Basque Health Service, known as Osakidetza, is a public healthcare organization dedicated to providing high-quality health services to the population of the Basque Country, Spain. As a clinical trial sponsor, Osakidetza is committed to advancing medical research and improving patient outcomes through rigorous scientific investigation. The organization actively collaborates with academic institutions, healthcare professionals, and industry partners to facilitate innovative clinical trials across various therapeutic areas. With a focus on ethical standards and patient safety, the Basque Health Service aims to contribute significantly to the global medical community by generating evidence-based solutions that enhance healthcare delivery and promote public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vitoria Gasteiz, Alava, Spain
Patients applied
Trial Officials
IÑAKI AGUIRREZABAL
Principal Investigator
Basque Health Service
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials